BioCardia CEO Peter Altman to Present at H.C. Wainwright Annual Global Investment Conference in New York City

jueves, 4 de septiembre de 2025, 9:01 am ET1 min de lectura
BCDA--

BioCardia's CEO, Peter Altman, will present a corporate update at the H.C. Wainwright 27th Annual Global Investment Conference in New York City from September 8-10, 2025. Altman will discuss the company's three clinical cell therapy programs for ischemic heart disease, regulatory activities, and recent partnerships. He will also be available for in-person one-on-one meetings with investors.

BioCardia CEO Peter Altman to Present at H.C. Wainwright Annual Global Investment Conference in New York City

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios